» Articles » PMID: 23286373

Analysis of Colorectal Cancers in British Bangladeshi Identifies Early Onset, Frequent Mucinous Histotype and a High Prevalence of RBFOX1 Deletion

Abstract

Background: Prevalence of colorectal cancer (CRC) in the British Bangladeshi population (BAN) is low compared to British Caucasians (CAU). Genetic background may influence mutations and disease features.

Methods: We characterized the clinicopathological features of BAN CRCs and interrogated their genomes using mutation profiling and high-density single nucleotide polymorphism (SNP) arrays and compared findings to CAU CRCs.

Results: Age of onset of BAN CRC was significantly lower than for CAU patients (p=3.0 x 10-5) and this difference was not due to Lynch syndrome or the polyposis syndromes. KRAS mutations in BAN microsatellite stable (MSS) CRCs were comparatively rare (5.4%) compared to CAU MSS CRCs (25%; p=0.04), which correlates with the high percentage of mucinous histotype observed (31%) in the BAN samples. No BRAF mutations was seen in our BAN MSS CRCs (CAU CRCs, 12%; p=0.08). Array data revealed similar patterns of gains (chromosome 7 and 8q), losses (8p, 17p and 18q) and LOH (4q, 17p and 18q) in BAN and CAU CRCs. A small deletion on chromosome 16p13.2 involving the alternative splicing factor RBFOX1 only was found in significantly more BAN (50%) than CAU CRCs (15%) cases (p=0.04). Focal deletions targeting the 5' end of the gene were also identified. Novel RBFOX1 mutations were found in CRC cell lines and tumours; mRNA and protein expression was reduced in tumours.

Conclusions: KRAS mutations were rare in BAN MSS CRC and a mucinous histotype common. Loss of RBFOX1 may explain the anomalous splicing activity associated with CRC.

Citing Articles

Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer.

Skalickova M, Hadrava Vanova K, Uher O, Leischner Fialova J, Petrlakova K, Masarik M Front Immunol. 2025; 15:1479483.

PMID: 39850897 PMC: 11754201. DOI: 10.3389/fimmu.2024.1479483.


Identification of hub genes distinguishing subtypes in endometrial stromal sarcoma through comprehensive bioinformatics analysis.

Zhang R, Zhao W, Zhu X, Liu Y, Ding Q, Yang C Sci Rep. 2024; 14(1):37.

PMID: 38167455 PMC: 10761685. DOI: 10.1038/s41598-023-47668-7.


A Transcriptome and Methylome Study Comparing Tissues of Early and Late Onset Colorectal Carcinoma.

Kibriya M, Raza M, Quinn A, Kamal M, Ahsan H, Jasmine F Int J Mol Sci. 2022; 23(22).

PMID: 36430738 PMC: 9697435. DOI: 10.3390/ijms232214261.


SCClone: Accurate Clustering of Tumor Single-Cell DNA Sequencing Data.

Yu Z, Du F, Song L Front Genet. 2022; 13:823941.

PMID: 35154282 PMC: 8830741. DOI: 10.3389/fgene.2022.823941.


Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma.

Bastidas Torres A, Melchers R, van Grieken L, Out-Luiting J, Mei H, Agaser C Haematologica. 2021; 107(7):1619-1632.

PMID: 34382383 PMC: 9244823. DOI: 10.3324/haematol.2020.263251.


References
1.
Winawer S, Fletcher R, Miller L, Godlee F, Stolar M, Mulrow C . Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997; 112(2):594-642. DOI: 10.1053/gast.1997.v112.agast970594. View

2.
Kaida D, Schneider-Poetsch T, Yoshida M . Splicing in oncogenesis and tumor suppression. Cancer Sci. 2012; 103(9):1611-6. PMC: 7659361. DOI: 10.1111/j.1349-7006.2012.02356.x. View

3.
Reid J, Gariboldi M, Sokolova V, Capobianco P, Lampis A, Perrone F . Integrative approach for prioritizing cancer genes in sporadic colon cancer. Genes Chromosomes Cancer. 2009; 48(11):953-62. DOI: 10.1002/gcc.20697. View

4.
Berger M, Hodis E, Heffernan T, Deribe Y, Lawrence M, Protopopov A . Melanoma genome sequencing reveals frequent PREX2 mutations. Nature. 2012; 485(7399):502-6. PMC: 3367798. DOI: 10.1038/nature11071. View

5.
Caspari R, Friedl W, Mandl M, Moslein G, Kadmon M, Knapp M . Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer. Lancet. 1994; 343(8898):629-32. DOI: 10.1016/s0140-6736(94)92634-4. View